Skip to content

DAXANT: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

DAXANT

BE 0426.468.616
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€33,995
2024 · €101,840-€67,846
Equity
€729,979
2024 · €695,984+€33,995
Cash
€281,216
2024 · €471,126-€189,910
Balance sheet total
€2.0m
2024 · €1.5m+€553,895

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€688,784

    up €688,784 (+142.1%), from €484,847 to €1.2m

    of which Trade receivables: +€680,744

  • Cash -€189,910

    down €189,910 (-40.3%), from €471,126 to €281,216

    mainly Receivables within one year (-€688,784) and Investment in fixed assets (net) (-€100,817)

  • Financial fixed assets +€99,235

    up €99,235 (+1261.0%), from €7,870 to €107,105

  • Tangible fixed assets -€33,502

    down €33,502 (-6.6%), from €505,016 to €471,515

    of which Land and buildings: -€23,125

Equity and liabilities
  • Trade debts +€499,696

    up €499,696 (+580.3%), from €86,112 to €585,808

  • Profit (loss) carried forward +€31,932

    no longer reported in 2025 (was -€31,932)

Income statement
  • Gross operating margin -€40,981

    down €40,981 (-20.6%), from €198,467 to €157,486

  • Provisions +€11,899

    no longer reported in 2025 (was -€11,899)

  • Taxes +€10,278

    new in 2025: €10,278

  • Staff costs +€8,112

    up €8,112 (+17.3%), from €46,904 to €55,016

  • Other operating charges -€6,134

    down €6,134 (-49.3%), from €12,431 to €6,298

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €101,840
Gross operating margin -€40,981
Staff costs -€8,112
Depreciation +€2,794
Provisions -€11,899
Other operating charges +€6,134
Financial income +€142
Financial charges -€5,645
Taxes -€10,278
Result 2025 €33,995

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€89,080
Investment -€100,817
Financing -€13
Cash 2024 €471,126
Net result for the year +€33,995
Depreciation +€35,083
Stocks and contracts +€5,725
Receivables within one year -€688,784
Deferred charges and accrued income +€4,988
Trade debts +€499,696
Tax, wage and social debts +€227
Other debts +€19,991
Investment in fixed assets (net) -€100,817
Current portion of long-term debt -€13
Cash 2025 €281,216
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,481,397 €2,035,292 +€553,895 +37.4%
Fixed assets 21/28 €512,886 €578,620 +€65,734 +12.8%
Tangible fixed assets 22/27 €505,016 €471,515 -€33,502 -6.6%
Land and buildings 22 €460,689 €437,565 -€23,125 -5.0%
Plant, machinery and equipment 23 €40,022 €31,666 -€8,356 -20.9%
Furniture and vehicles 24 €4,305 €2,284 -€2,021 -46.9%
Financial fixed assets 28 €7,870 €107,105 +€99,235 +1261.0%
Current assets 29/58 €968,511 €1,456,672 +€488,161 +50.4%
Stocks and contracts in progress 3 €7,041 €1,317 -€5,725 -81.3%
Stocks 30/36 €7,041 €1,317 -€5,725 -81.3%
Amounts receivable within one year 40/41 €484,847 €1,173,631 +€688,784 +142.1%
Trade receivables 40 €326,360 €1,007,104 +€680,744 +208.6%
Other amounts receivable 41 €158,487 €166,527 +€8,040 +5.1%
Cash at bank and in hand 54/58 €471,126 €281,216 -€189,910 -40.3%
Deferred charges and accrued income 490/1 €5,497 €508 -€4,988 -90.8%
Total equity and liabilities 10/49 €1,481,397 €2,035,292 +€553,895 +37.4%
Equity 10/15 €695,984 €729,979 +€33,995 +4.9%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €665,916 €667,979 +€2,062 +0.3%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €659,716 €661,779 +€2,062 +0.3%
Profit (loss) carried forward 14 -€31,932 - +€31,932
Amounts payable 17/49 €785,413 €1,305,313 +€519,900 +66.2%
Amounts payable within one year 42/48 €785,413 €1,305,313 +€519,900 +66.2%
Current portion of amounts payable after more than one year 42 €1,701 €1,688 -€13 -0.8%
Financial debts 43 €150,000 €150,000 = 0.0%
Credit institutions 430/8 €150,000 €150,000 = 0.0%
Trade debts 44 €86,112 €585,808 +€499,696 +580.3%
Suppliers 440/4 €86,112 €585,808 +€499,696 +580.3%
Taxes, remuneration and social security 45 €4,961 €5,188 +€227 +4.6%
Remuneration and social security 454/9 €4,961 €5,188 +€227 +4.6%
Other amounts payable 47/48 €542,638 €562,629 +€19,991 +3.7%
Remuneration, social security and pensions 62 €46,904 €55,016 +€8,112 +17.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €37,877 €35,083 -€2,794 -7.4%
Provisions for liabilities and charges: additions (uses and reversals) 635/8 -€11,899 - +€11,899
Other operating charges 640/8 €12,431 €6,298 -€6,134 -49.3%
Gross operating margin 9900 €198,467 €157,486 -€40,981 -20.6%
Operating profit (loss) 9901 €113,154 €61,089 -€52,065 -46.0%
Financial income 75/76B €2,993 €3,135 +€142 +4.7%
Recurring financial income 75 €2,993 €3,135 +€142 +4.7%
Financial charges 65/66B €14,306 €19,952 +€5,645 +39.5%
Recurring financial charges 65 €14,306 €19,952 +€5,645 +39.5%
Profit (loss) for the period before taxes 9903 €101,840 €44,272 -€57,568 -56.5%
Income taxes 67/77 - €10,278 +€10,278
Profit (loss) for the period 9904 €101,840 €33,995 -€67,846 -66.6%
Profit (loss) for the period to be appropriated 9905 €101,840 €33,995 -€67,846 -66.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.